OBJECTIVE: Cognitive problems are commonly reported by hematopoietic stem cell transplant (HSCT) survivors and are associated with poorer physical and mental well-being. It was hypothesized that adverse effects of subjective cognitive impairment occur because cognitive difficulties reduce survivors' confidence that they can manage HSCT-related symptoms-that is, self-efficacy for symptom management. METHODS: Hematopoietic stem cell transplant survivors (n = 245), 9 months to 3 years post-HSCT, completed measures of subjective cognitive functioning, self-efficacy for symptom management, and clinically important outcomes: depressed mood, anxiety, and quality of life. Mediation analyses using bootstrapping were conducted to investigate whether effects of subjective cognitive impairment on these outcomes were mediated by self-efficacy for cognitive, emotional (SE-Emotional), social (SE-Social), and physical (SE-Physical) symptom management. RESULTS: Self-efficacy mediated relations between subjective cognitive impairment and depressed mood (total indirect effect = -0.0064 and 95% CI -0.0097 to -0.0036), anxiety (total indirect effect = -0.0045, CI -0.0072 to -0.0021), and quality of life (total indirect effect = 0.0952, CI 0.0901 to 0.2642). SE-Emotional was a unique mediator when the outcome was depressed mood and anxiety. SE-Social, SE-Physical, and SE-Emotional were specific mediators when outcome was quality of life. CONCLUSIONS: Findings support the conclusion that subjective cognitive impairment reduces HSCT survivors' confidence in their ability to manage common post-HSCT symptoms, with implications for physical and mental well-being. Interventions that help enhance survivors' self-efficacy, particularly self-efficacy for the management of emotional symptoms, are likely to benefit HSCT survivors who report subjective cognitive impairment.
OBJECTIVE: Cognitive problems are commonly reported by hematopoietic stem cell transplant (HSCT) survivors and are associated with poorer physical and mental well-being. It was hypothesized that adverse effects of subjective cognitive impairment occur because cognitive difficulties reduce survivors' confidence that they can manage HSCT-related symptoms-that is, self-efficacy for symptom management. METHODS: Hematopoietic stem cell transplant survivors (n = 245), 9 months to 3 years post-HSCT, completed measures of subjective cognitive functioning, self-efficacy for symptom management, and clinically important outcomes: depressed mood, anxiety, and quality of life. Mediation analyses using bootstrapping were conducted to investigate whether effects of subjective cognitive impairment on these outcomes were mediated by self-efficacy for cognitive, emotional (SE-Emotional), social (SE-Social), and physical (SE-Physical) symptom management. RESULTS: Self-efficacy mediated relations between subjective cognitive impairment and depressed mood (total indirect effect = -0.0064 and 95% CI -0.0097 to -0.0036), anxiety (total indirect effect = -0.0045, CI -0.0072 to -0.0021), and quality of life (total indirect effect = 0.0952, CI 0.0901 to 0.2642). SE-Emotional was a unique mediator when the outcome was depressed mood and anxiety. SE-Social, SE-Physical, and SE-Emotional were specific mediators when outcome was quality of life. CONCLUSIONS: Findings support the conclusion that subjective cognitive impairment reduces HSCT survivors' confidence in their ability to manage common post-HSCT symptoms, with implications for physical and mental well-being. Interventions that help enhance survivors' self-efficacy, particularly self-efficacy for the management of emotional symptoms, are likely to benefit HSCT survivors who report subjective cognitive impairment.
Authors: R P McQuellon; G B Russell; D F Cella; B L Craven; M Brady; A Bonomi; D D Hurd Journal: Bone Marrow Transplant Date: 1997-02 Impact factor: 5.483
Authors: Karen L Syrjala; Shelby L Langer; Janet R Abrams; Barry Storer; Jean E Sanders; Mary E D Flowers; Paul J Martin Journal: JAMA Date: 2004-05-19 Impact factor: 56.272
Authors: Lisa M Wu; Nadia Kuprian; Krista Herbert; Ali Amidi; Jane Austin; Heiddis Valdimarsdottir; Christine Rini Journal: Palliat Support Care Date: 2019-08
Authors: Lisa M Wu; Molly L Tanenbaum; Marcel P J M Dijkers; Ali Amidi; Simon J Hall; Frank J Penedo; Michael A Diefenbach Journal: Soc Sci Med Date: 2016-03-17 Impact factor: 4.634
Authors: Shannon M Nugent; Sara E Golden; Charles R Thomas; Mark E Deffebach; Mithran S Sukumar; Paul H Schipper; Brandon H Tieu; Drew Moghanaki; Juan Wisnivesky; Christopher Slatore Journal: Support Care Cancer Date: 2017-12-05 Impact factor: 3.603
Authors: Hermioni L Amonoo; Christina N Massey; Melanie E Freedman; Areej El-Jawahri; Halyna L Vitagliano; William F Pirl; Jeff C Huffman Journal: Psychosomatics Date: 2019-02-14 Impact factor: 2.386
Authors: Ali Amidi; Lisa M Wu; Anders Degn Pedersen; Mimi Mehlsen; Christina Gundgaard Pedersen; Philip Rossen; Mads Agerbæk; Robert Zachariae Journal: Support Care Cancer Date: 2015-02-26 Impact factor: 3.603
Authors: Jessica P Hwang; Aimee K Roundtree; Sergio A Giralt; Maria Suarez-Almazor Journal: BMJ Support Palliat Care Date: 2012-08-03 Impact factor: 3.568
Authors: Kelly Kenzik; I-Chan Huang; J Douglas Rizzo; Elizabeth Shenkman; John Wingard Journal: Support Care Cancer Date: 2014-09-06 Impact factor: 3.603